Efficacy of Quantum Molecular Resonance in Neuropathic Corneal Pain and Corneal Nerve Regeneration

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions
Neuropathic Corneal Pain
Interventions
DEVICE

Quantum Molecular Resonance (QMR) Treatment

Quantum Molecular Resonance (QMR) treatment will be administered using the Rexon-Eye® device (Resono Ophthalmic, Sandrigo, Italy) according to the protocol recommended by the manufacturer. The device features a contact electrode embedded in a mask worn over the participant's closed eyes, and it delivers stimulation to the epidermis of the closed eyelids, extending up to the lid border with an intensity setting of 4-5 on a scale of 0-10. The treatment is non-invasive and painless.

Trial Locations (1)

S169856

RECRUITING

Singapore National Eye Centre, Singapore

All Listed Sponsors
lead

Singapore Eye Research Institute

OTHER

NCT07174739 - Efficacy of Quantum Molecular Resonance in Neuropathic Corneal Pain and Corneal Nerve Regeneration | Biotech Hunter | Biotech Hunter